NCT07659223

Brief Summary

Children and parents often experience uncertainty and stress when juvenile idiopathic arthritis (JIA) is first diagnosed, which creates a need for structured support. Juvenile Idiopathic Support Program (JASP-1) provide patient-and family centered support during the first year after diagnosis. However, little is known about how a support program like JASP-1 can influence outcomes. Therefore, this study aimed to longitudinally examine registry data from children who participated in JASP 1 and to compare the outcomes with registry data from a matched control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2019

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2026

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
Last Updated

June 22, 2026

Status Verified

May 1, 2026

Enrollment Period

6.5 years

First QC Date

May 26, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

JIASupport-program,Register study

Outcome Measures

Primary Outcomes (4)

  • CHAQ, Disabkids, Physicians global assessment

    56 children received JASP-1and was on 3 timepoints compared with 60 children matched in disease, gender and age.The measures compared is CHAQ including pain, disease impact on overall well-being and school attendance, DISABKIDS, JADAS-71, Physicians global assessment, Number of active joints, Number of joint injections and Pharmacological treatment. Outcomes at 12 months, were analyzed using the non parametric Mann-Whitney U test. For categorical variables differences were analyzed using the chi-square test to compare proportions. Repeated measurement ANOVA was used for calculating differences over time between the two groups. P value \< 0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics for Windows, version 31.

    For one year following JIA diagnosis

  • CHAQ

    Childhood Health Assessment Queationnaire

    Assessed several times during the first year after diagnosis. Values from 0-3

  • Disabkids

    Health Related Quality of Life

    Assessed at 3 timepoints during the first year, values between 0-100

  • Phycisians global assessment

    Assessed at 3 timepoint during the first year after diagnosis. Valued on a VAS scale 0-10

    During the first year after diagnosis

Study Arms (2)

Participating in the Juvenile Arthritis Support Program (JASP-1)

EXPERIMENTAL

Children newly diagnosed with JIA and their parents were invited to participate in the intervention JASP-1. The intervention contains seven structured patient-and family centered visits the first year after JIA diagnose. With more visits close in the beginning.

Behavioral: The intervention was a one year support program JASP-1

Control group

NO INTERVENTION

This arm is a control group consisting of 60 children matched in diagnose, gender and age with the ones in the intervention group. The children and parents in the control group did not receive any intervention. The data was collected from the PedSRQ register.

Interventions

Seven structured visits with a patient-and family-centered approach was used in the JASP-1 program, in which children newly diagnosed with JIA and their parents were invited to participate in.

Participating in the Juvenile Arthritis Support Program (JASP-1)

Eligibility Criteria

Age0 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • For the JASP-1: Diagnosed with JIA and have completed the JASP-1.
  • For the control group: Diagnosed with JIA at the same clinic as above

You may not qualify if:

  • No JIA diagnosis
  • Change of diagnose during the year
  • Do not understand or speak Swedish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 17176, Sweden

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The intervention JASP-1 is a support program consisting of seven structured visits the first year following JIA diagnosis
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 22, 2026

Study Start

August 15, 2019

Primary Completion

February 19, 2026

Study Completion

February 19, 2026

Last Updated

June 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations